Author: Business Wire

Tilak Strengthens Its Governance

PARIS–(BUSINESS WIRE)–Tilak, a start-up from the iBionext network developing mobile medical applications for the management of chronic diseases, has re-structured with the creation of a medical department, and strengthened its game developer team. Tilak has assembled a team of experienced multidisciplinary experts from the medical and mobile gaming worlds, with the ambition of providing solutions used routinely by both doctors and patients, to improve the care pathway. Odysight is Tilak’s fir

Avedro Celebrates 10 Year Anniversary

WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc. today announced that it has reached a milestone, celebrating 10 years of scientific research, innovation and business. Since its founding in 2008, Avedro has grown from a small R&D company to an internationally recognized ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling. “Avedro’s 10-year journey began with the exploration of using microwave technology to reshape the cornea,” said Reza Zadno, PhD, C

Keen Eye: Fighting Cervical Cancer: A Deep Learning Solution to Help the Screening of the Disease

PARIS–(BUSINESS WIRE)–The solution developed by Keen Eye, a French startup specialized in digital technology, has caught the attention of the jury* of the French 7th edition of the Concours d’Innovation Numérique in the category « live better », organized by Bpifrance and financed by the Programme d’Investissements d’Avenir (PIA). Keen Eye solution aims at providing to experts in pathology laboratories powerful tools of machine learning, to accelerate and save thousands of hours of manual ana

Singapore Eyewear Market 2017-2021 by Type, Sunglasses & Eyeglasses, and Sales Channel – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Singapore Eyewear Market by Type (Spectacles & Contact Lenses), By Sunglasses and Eyeglasses and by Sales Channel – Outlook to 2021” report has been added to ResearchAndMarkets.com’s offering. The report includes the government initiatives and regulations in Singapore eyewear market, competitive landscape and company profiles for major players in the eyewear market. The report provides detailed overview on the general features of eyewear in the country and futu

GenSight Biologics annonce les résultats de l’essai clinique de phase III REVERSE sur GS010 chez des patients atteints de Neuropathie Optique Héréditaire de Leber (NOHL)

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris: SIGHT)(Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques innovantes pour le traitement des maladies neurodégénératives de la rétine et du système nerveux central, annonce aujourd’hui les résultats préliminaires de l’essai clinique de phase III REVERSE évaluant la sécurité et l’efficacité d’une unique injection intravitréenne de GS

ソウル半導体、欧州で「ヒューマンセントリック照明と健康」をテーマとするシンポジウムを開催

韓国安山市–(BUSINESS WIRE)–(ビジネスワイヤ) — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社:韓国安山市、代表理事:李貞勲、以下「ソウル半導体」)は、光が健康と生体リズムに与える影響を、科学的、客観的に究明したシンポジウムを、世界最大級の照明展示会Light & Buildingで開催したことを発表した。ドイツ・フランクフルトで開催されたシンポジウムでは、「ヒューマンセントリック照明と健康」がテーマとして扱われた。 今回のシンポジウムでは、すでにBBCドキュメンタリー体内時計でよく知られている光と睡眠、生体リズムの研究分野の世界的権威であるオックスフォード大学のラッセル・フォスター(Russell Foster)博士、オックスフォード大学のマニュエル・スピッチェン(Manuel Spitschan)博士、ニューヨークのMount Sinai Hospitalのオクタビオ・ペレス(Octavio L. Perez)博士が講演者として参加し、光が睡眠と健康、生体リズムに与える影響につい

CareCloud to Host First User Summit in Miami, September 7-9, 2018

MIAMI–(BUSINESS WIRE)–#RCM–CareCloud, the platform for high-performing medical groups today announced that its first user summit – hosting the country’s fastest growing physician practices – will be held at the Hilton Miami Downtown. Beginning September 7, CloudUP ’18, will inspire practice leaders to use technology in new ways to modernize the patient experience and to improve every aspect of running a practice in today’s competitive environment. During CloudUP ’18, hundreds of tech forward pract

Presbyopia Therapeutics Pipeline Analysis 2018 – Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Presbyopia Therapeutics – Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments” report has been added to ResearchAndMarkets.com’s offering. The study analyzed that the presbyopia therapeutics pipeline comprises nine drug candidates in different stages of development. Presbyopia is an age-related eye condition that causes visual impairment gradually. The disease has been described as “an irreversible opt